ENTO — Entero Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Entero Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	6.06	8.25	1.36	3.71	0.163
Net Total Receivables	0.551	0	0.093	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7.87	9.42	3.41	4.96	83.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.093	0.409	0.303	0.21	0.127
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	12.9	11.8	5.44	6.88	85.4
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	15.5	12.3	2.48	3.13	27.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.6	19.6	2.7	3.28	27.6
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-2.64	-7.82	2.74	3.6	57.8
Total Liabilities & Shareholders' Equity	12.9	11.8	5.44	6.88	85.4
Total Common Shares Outstanding
Total Preferred Shares Outstanding